Optimization of systemic AAV9 gene therapy in Niemann-Pick disease type C1 mice
Avani V. Mylvara, Alana L. Gibson, Tansy Gu, Cristin D. Davidson, Arturo A. Incao, Katerina D Melnyk, Susan Gembic, Dominick Pierre-Jacques, Stephanie M. Cologna, Charles P. Venditti, Forbes D. Porter, William J. Pavan
This study evaluates the efficacy of systemic AAV9-hNPC1 gene therapy in NPC1 mouse models, finding that higher doses and earlier treatment improve survival and slow disease progression.
Life Science Alliance · Mar 18, 2026Peer-reviewedNeuroscience